SCHEMBL19853697

SCHEMBL19853697

NC(=O)[C@H](CS)N1CC2(CCN(OCc3ccccc3)CC2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.37
ALDH1A1 P00352 3/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP2C19 P33261 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CTRB1 P17538 3/20 0.33
DPP4 P27487 1/20 0.33
KCNH2 Q12809 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
ADAM17 P78536 1/20 0.33
TACR1 P25103 2/20 0.33
CYP2D6 P10635 2/20 0.33
LIPE Q05469 1/20 0.32
CRBN Q96SW2 1/20 0.32
TSHR P16473 1/20 0.32
SLC1A3 P43003 2/20 0.32
SLC1A2 P43004 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19853696 0.85 DPP4 (0.43) ALDH1A1POLBL3MBTL1CYP2C19SMN1; SMN2
SCHEMBL19853721 0.85 DPP4 (0.43) ALDH1A1POLBL3MBTL1CYP2C19SMN1; SMN2
SCHEMBL19853771 0.82 GRIN2B (0.41) RIPK1ALDH1A1CYP2C19SMN1; SMN2DPP4
SCHEMBL19853693 0.77 RIPK1 (0.48) RIPK1ALDH1A1CYP2C19SMN1; SMN2CYP2D6
SCHEMBL19853717 0.75 DPP4 (0.44) ALDH1A1POLBL3MBTL1CYP2C19SMN1; SMN2
SCHEMBL19853770 0.75 DPP4 (0.44) ALDH1A1POLBL3MBTL1CYP2C19SMN1; SMN2
SCHEMBL21034522 0.74 LMNA (0.31)
SCHEMBL19854375 0.74 LMNA (0.36)
SCHEMBL19853720 0.73 DPP4 (0.41) DPP4MEN1KMT2A
SCHEMBL21034288 0.73 LMNA (0.33) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026763-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC. (US) 2018-02-08 WO disclosed